Viral Protector

A retrovirus embedded in the human genome may help protect embryos from other viruses, and influence fetal development.

Written byJef Akst
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, ELIFESome 9 percent of the human genome of is viral origin, and while the genetic material was long dismissed as useless junk DNA, recent research has demonstrated that many of these sequences are not always inactive. One of these so-called endogenous retroviruses, HERVK, is apparently expressed in human embryos, according to a study published this week (April 20) in Nature, and appears to play critical roles in viral defense and early development.

“The cells were full of viral [HERVK] protein products, some of which had assembled to form viral-like particles,” coauthor Joanna Wysocka of Stanford University told New Scientist of the three-day-old embryos she and her colleagues investigated. The viral products included a protein that prevented other viruses, such as influenza, from penetrating the embryo and coordinated the translation of certain host RNAs.

“[The work] shows that the protein products of a relatively ‘recent’ retrovirus integration”—HERVK took up residence in the human genome just 200,000 years ago—“are present very early on in the embryo, and could be involved in some critical developmental programs,” the Pasteur Institute’s Patrick Forterre, who was not involved in the research, told New Scientist.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies